Clinical Trial Update: A Study of Deuremidevir Hydrobromide for Suspension in Chinese Infants Hospitalized With RSV [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Deuremidevir Hydrobromide for Suspension in Chinese infants hospitalized with Respiratory Syncytial Virus infection has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• Deuremidevir Hydrobromide for Suspension (Deuremidevir Hydrobromide)

Snippet

Sponsor: Vigonvita Life Sciences | Conditions: Respiratory Syncytial Virus Infection | Phase 2 | Status: COMPLETED